Expression of interleukin -12 and correlation between interleukin -12 and eosinophils in nasal mucosa in allergic rhinitis mice
deng qiu, Zhou Yun, yang jun, Erzhong Fan
Abstract
deng qiu, Zhou Yun, yang jun, Erzhong Fan
Abstract
OBJECTIVE To observe the expres-sion of interleukin-12 and eosinophils in the nasal mu-cosa of allergic rhinitis mice. METHODS Thirty nine male BALB/c mice,6~8 weeks old,were randomly divided into three groups: control group,allergic rhinitis (AR)group, and Budesonide treatment group. Al-lergic rhinitis model in mice were established by using ovalbumin intraperitoneal immunization and nasal anti-gen challenge. The nasal mucosa obtained from mice of three groups were stained routinely by HE and im-munohistochemical method to observe the distribu-tion and expression of interleukin-12 and eosinophils. RESULTS The expression of eosinophils in the nasal mucosa of AR group was significantly higher than con-trol group(P0.01). After treatment with Budes-onide,eosinophils’expression were decreased in nasal mucosa(P0.01,compared with the AR group). However,interleukin-12 expression was significantly increased compared with AR group(P 0.01),and had no significant difference compared with the control group. There was a negative relation-ship between the expression of interleukin-12 and eosino-phil in nasal mucosa (R =0.9252). CONCLUSION The abnormal expression of interleukin-12 in the nasal mu-cosa played an important role in the pathogenic mecha-nism of AR. The recovery or increase expression of interleukin-12 in topical tissue in vivo could suppress the expression of eosinophils and may improve the therapeutic effectiveness of AR.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To observe the expres-sion of interleukin-12 and eosinophils in the nasal mu-cosa of allergic rhinitis mice. METHODS Thirty nine male BALB/c mice,6~8 weeks old,were randomly divided into three groups: control group,allergic rhinitis (AR)group, and Budesonide treatment group. Al-lergic rhinitis model in mice were established by using ovalbumin intraperitoneal immunization and nasal anti-gen challenge. The nasal mucosa obtained from mice of three groups were stained routinely by HE and im-munohistochemical method to observe the distribu-tion and expression of interleukin-12 and eosinophils. RESULTS The expression of eosinophils in the nasal mucosa of AR group was significantly higher than con-trol group(P0.01). After treatment with Budes-onide,eosinophils’expression were decreased in nasal mucosa(P0.01,compared with the AR group). However,interleukin-12 expression was significantly increased compared with AR group(P 0.01),and had no significant difference compared with the control group. There was a negative relation-ship between the expression of interleukin-12 and eosino-phil in nasal mucosa (R =0.9252). CONCLUSION The abnormal expression of interleukin-12 in the nasal mu-cosa played an important role in the pathogenic mecha-nism of AR. The recovery or increase expression of interleukin-12 in topical tissue in vivo could suppress the expression of eosinophils and may improve the therapeutic effectiveness of AR.
Key concepts: Mucous membrane of nose, Ovalbumin, Medicine, Interleukin 5, Budesonide, Interleukin, Nasal administration, Interleukin 4